The fundamental question of which genes are most important in controlling liver regeneration remains unanswered. We employed a parallel screen to test the impact of 43 selected genes on liver repopulation in the Fah −/− mouse model of hereditary tyrosinemia. We discovered that the transcription factor Foxa3 was a strong promoter of liver regeneration, while tumor necrosis factor receptor 1 (TNFR1) was the most significant suppressor of repopulation among all of the genes tested. Our approach enabled the identification of these factors as important regulators of liver repopulation and potential drug targets for the promotion of liver repopulation.
A better understanding of how the liver regenerates in its attempts to recover from injuries, such as from exposure to drugs or alcohol or from infection by hepatitis viruses, could lead to new treatments with immense impact on the natural history of liver diseases. Previous efforts have relied on the easily accessible partial hepatectomy model in rodents (Fausto and Mead 1989; Fausto 1990 Fausto , 2000 Fausto , 2004 Fausto et al. 1995; Michalopoulos 2010) , and many candidate genes were identified by expression profiling after partial hepatectomy (Kelley-Loughnane et al. 2002; Su et al. 2002; Fukuhara et al. 2003; White et al. 2005; Guo and Xu 2008; Cao et al. 2009; Li et al. 2009; Jiang et al. 2011; Schug et al. 2013 ). These results have implicated numerous pathways as being involved in regeneration, including growth factor pathways, kinases, transcription factors, and nuclear receptors, but did not inform us on the relative impact of the various genes on liver repopulation following toxic injury. Sequencing of multiple hepatocellular carcinomas (HCCs) identified a number of regulators of proliferation as well (Nishida and Kudo 2013; Tornesello et al. 2013) . Despite an abundant number of genes that have been identified, no single gene, when mutated in animal models, seems to be absolutely required for the recovery of liver mass following partial hepatectomy, suggesting that genetic redundancy may be an adaptation for such an important and conserved biological process as liver regeneration (Vogel 2006) .
Genetic screens could be used to sort out the pathways that are key to the genetic control of liver regeneration. Recently, a shRNA screen of genes mutated in HCC was employed in a repopulation model to suggest the map kinase MKK4 as a regulator of liver repopulation (Wuestefeld et al. 2013) . The experimental paradigm used was the Fah −/− mouse model of liver repopulation, which has a defect in the last step of tyrosine catabolism, resulting in accumulation of the toxic metabolite fumarylacetoacetate (FAA) and injury to hepatocytes (Grompe 2001) . Fah −/− mice can be kept alive by treatment with 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione (NTBC), a drug that inhibits an upstream enzyme in the tyrosine catabolic cascade to prevent formation of FAA. This model has been used to perform repopulation assays in the liver, where Fah-expressing hepatocytes divide and replace mutant hepatocytes after NTBC has been removed from the drinking water. We hypothesized that a competitive overexpression screen of genes implicated in controlling liver regeneration could identify factors that promote or inhibit liver repopulation in Fah −/− mice.
Results and Discussion
We constructed a library of plasmids in which the FAH transgene was linked to 43 potential positive and negative regulators as well as the reporter gene GFP as a neutral control ( Fig. 1A ; Supplemental Table S1 ). The genes were selected with an emphasis on transcription factors and potentially targetable protein products, such as cell surface and nuclear hormone receptors, cytokine receptors, and kinases. Genes were identified after a careful review of the literature on the genetic control of liver regeneration, major common insertion sites for genes identified in cancer genome sequencing projects, and role in liver stem cell biology and development. For genes in the latter category (namely, Foxa1, Foxa2, Foxa3, Foxl1, and Lgr5), little or no a priori data existed on their role in liver regeneration. Using the hydrodynamic injection technique (Liu et al. 1999; Zhang et al. 1999; Wilber et al. 2005; Wangensteen et al. 2008) , the pool of 43 transgenes and GFP control constructs was stably introduced into a minority of hepatocytes in Fah −/− mice (estimated to be ∼0.1%; Montini et al. 2002) . Two days later, Fah-expressing hepatocytes were stimulated to undergo selective repopulation by removing the drug NTBC, which prevents toxin formation in Fah-deficient hepatocytes by inhibiting an upstream enzymatic step (Grompe 2001) . Mouse livers were harvested at predetermined time points after removal of NTBC, DNA was extracted, and high-throughput sequencing was performed to determine the prevalence of each of the plasmids (Fig. 1B) .
We verified that the constructs mediated repopulation of the livers of Fah −/− mice by performing immunohistochemistry (IHC) staining for Fah, which revealed expansion of Fah-positive hepatocyte nodules over the 6-wk time course (Fig. 2A) . There was significant heterogeneity in nodule size, suggesting a differential effect on clonal outgrowth by the constructs. Whole DNA extracted from two large liver lobes at days 0, 14, 28, and 42 after injection and removal of NTBC (N ≥ 3 for each time point) was amplified using primers common to all plasmids. The region amplified encompassed 5-nucleotide (nt) barcodes, which were high-throughput-sequenced. The read count was converted to prevalence for each plasmid over the time course ( Fig. 2B ; Supplemental Table S2 ). Several of the transgenes dramatically changed in prevalence compared with the GFP control plasmid over time. cMyc and TGFα were the greatest promoters of liver repopulation, consistent with their function as proto-oncogenes (Ohgaki et al. 1996; Kaposi-Novak et al. 2009 ). cMyc became the predominant transgene at 6 wk, going from a frequency of reads of 1.3% (±0.02%) at the initial time point to 25% (±0.53) at 6 wk, which skewed the frequency of the remaining genes downward over time. Next in prevalence after cMyc and TGFα, surprisingly, was Foxa3, a forkhead transcription factor that was not previously known to play any role in regeneration. Foxa3 increased in frequency of reads from 2.0% (±0.05%) to 3.5% (± 0.7%) over time, as compared with GFP, which went from 1.4% (±0.03%) to 1.1% (±0.2%) (P = 0.033 for comparison of Foxa3 to GFP at 6 wk after normalization to the mean value of the initial time point). Unexpectedly, the strongest suppressor of repopulation was tumor necrosis factor receptor 1 (TNFR1), the receptor for TNFα, which decreased in frequency of reads from 1.1% (± 0.09%) to 0.098% (±0.02%) (P = 0.004 compared with GFP at 6 wk, after normalization to the mean value of the initial time point) (Byl et al. 1993) .
Foxa1, Foxa2, and Foxa3 are homologous forkhead transcription factors essential for liver development and are termed "pioneer factors" for their ability to access areas of heterochromatin to activate gene transcription (Zaret 1999; Le Lay and Kaestner 2010) . Foxa3 is the most highly expressed of the Foxa factors in the adult liver and is dispensable for liver development (Kaestner et al. 1994) . Foxa3 is one of three to four factors that are sufficient to convert fibroblasts into hepatocyte-like cells (Huang et al. 2011; Sekiya and Suzuki 2011) . We confirmed that Foxa3 overexpression indeed promotes liver regeneration by using a competitive repopulation assay (Fig. 3A) . We injected FAH-Foxa3 and FAH-GFP plasmids in equimolar amounts into Fah −/− mice (N = 3) and removed NTBC to stimulate repopulation. Four weeks after injection, we performed Foxa3 and GFP immunofluorescence and determined that the size and number of Foxa3-expressing repopulation nodules were greater than those of GFPexpressing nodules (Fig. 3B,C) . We performed quantitative PCR (qPCR) on extracted DNA to quantify the abundance of the two transgenes and found that FAH-Foxa3 was enriched compared with FAH-GFP after repopulation, confirming that Foxa3 indeed promotes liver repopulation (Fig. 3D) . TNFR1 is part of a family of cell surface proteins (commonly known as the death receptors) that are expressed at high levels in hepatocytes, possibly to trigger eradication of hepatocytes that become infected with viruses (Akazawa and Gores 2007). The ligand for TNFR1 is TNFα, a cytokine that becomes elevated in cirrhosis and alcoholic liver disease (Byl et al. 1993) . TNFα in rodents has been found to have a dichotomous role as a mitogen during liver regeneration after partial hepatectomy and as an activator of apoptosis in the setting of exposure to toxins such as alcohol (Bradham et al. 1998 ). The molecular context of TNFR1 activation is thought to dictate whether it supports the regenerative response or causes hepatocyte death (Luedde et al. 2014) . To verify whether TNFR1 expression inhibits liver repopulation, we injected either FAH-TNFR1 or an equimolar amount of FAH-GFP plasmid into separate Fah −/− mice (Fig. 4A) . We found that, as compared with mice injected with the FAH-GFP plasmids, mice injected with FAH-TNFR1 lost significantly more weight and exhibited increased mortality after removal of NTBC (Fig. 4B) . At 4 wk after injection, surviving mice from each group were euthanized. Analysis of serum chemistries indicated decreased albumin and markedly elevated total bilirubin, AST, and ALT with FAH-TNFR1 as compared with FAH-GFP, indicating that TNFR1 expression in repopulating liver cells leads to severe liver injury in Fah −/ − mice (N = 3 each) (Fig. 4C) . Immunohistochemical staining for FAH indicated significantly greater repopulation with FAH-GFP than with FAH-TNFR1 (N = 3 each) (Fig. 4D) . With FAH-TNFR1, the Fah-positive cells were dysmorphic and had heterogenous Fah staining intensity. We compared proliferation in the two groups by staining with the cell cycle marker Ki67 and found many more cells to be proliferating in FAH-GFP-treated livers than in FAH-TNFR1 1 mo after injection (Fig. 4E) . In contrast, p21, a marker of cell cycle arrest, was strongly induced in repopulating FAH-TNFR1-positive cells and was absent in FAH-GFP-repopulating hepatocytes (Fig. 4E) . Interestingly, TUNEL assay for apoptosis revealed only a few scattered TUNEL-positive cells in both groups (data not shown), consistent with previous reports that injured hepatocytes in Fah −/− mice undergo apoptosis arrest (Willenbring et al. 2008) . In summary, expression of TNFR1 in repopulating hepatocytes leads to a proliferation arrest with toxicity from inappropriate activation of the TNFR1 pathway and constitutive expression of the cell cycle inhibitor p21.
In conclusion, we used a competitive in vivo screening paradigm to discover Foxa3 and TNFR1 as critical modulators of liver repopulation. Previous efforts had identified pathways as being involved in liver regeneration following partial hepatectomy but had never compared multiple genes in a clinically relevant liver injury model. Our method enabled the direct comparison of overexpressed genes in repopulating liver cells. Foxa3 is a transcription factor that likely establishes a transcriptional program to potently enhance liver repopulation. TNFR1, in contrast, strongly inhibits liver repopulation, possibly by sensitizing hepatocytes to TNF signaling in the context of liver injury. Interestingly, we found that expression levels of both TNFR1 and its ligand, TNFα, increase twofold in the liver after partial hepatectomy in our previously published gene expression data set (Schug et al. 2013) . The disparate findings with TNF signaling in promotion of regeneration after partial hepatectomy as opposed to inhibition of repopulation in the Fah −/− model may be due to a sensitivity to level of activation of TNF signaling, the duration of injury, or the inflammatory context in toxic liver injury. Interestingly, a recent study demonstrated that blockade of TNF signaling with etanercept promoted engraftment of transplanted hepatocytes in a rat model (Viswanathan et al. 2014) . Taken together, these data suggest that inhibition of TNFR1 expression or activity in hepatocytes may represent a novel strategy to promote healthy repopulation in the context of toxic liver injury. 
Materials and methods

Plasmid construction and sequencing
Plasmid pKT2/FAH-CA//SB (Wangensteen et al. 2008 ) was used as the base plasmid to clone cDNAs downstream from a miniCagg promoter. cDNA for GFP was initially cloned at the EcoRI site, with BsiWI sequence added to the 3 ′ end to facilitate directional cloning. Mouse full-length cDNAs were PCR-amplified from plasmids obtained from repositories (PlasmID DNA Resource Core [Harvard University, Cambridge, MA] and Addgene) or mouse liver cDNA libraries. Primers used to amplify the cDNA all included 5
′ primers with an EcoRI restriction site and 3 ′ primers with a BsiWI site, the Illumina 5 ′ -ILMN sequencing primer sequence (5 ′ -CCCTACAC-GACGCTCTTCCGATCT-3 ′ ), and a unique 5-nt barcode sequence (Supplemental Table S1 ). The unique barcode sequences were generated using Barcode Generator free software (http://comailab.genomecenter. ucdavis.edu/index.php/Barcode_generator). Plasmids were all endotoxinfree maxi-prepped (Sigma), and Sanger sequencing was used to verify correct full-length sequences for all cDNAs. The library pool was generated by combining equimolar amounts of each plasmid.
For quantitative sequencing of the plasmid barcodes, whole DNA was extracted from a homogenate of two large liver lobes from mice euthanized at days 0, 14, 28, and 42 after injection (Qiagen). Two rounds of PCR were performed to amplify the sequences containing the unique barcodes using primers L-adapter (5 ′ -CCTACACGACGCTCTTCCGATCT-3 ′ ) and Radapter-1 (5 ′ -AGACGTGTGCTCTTCCGATCTCAGGGCATTGGCCA Cold Spring Harbor Laboratory Press on September 20, 2017 -Published by genesdev.cshlp.org Downloaded from CACCAG-3 ′ ) for the first round, followed by DNA purification and a second PCR round with universal adapter primer (5 ′ -AATGATACGGCGA CCACCGAGATCTACCACTCTTTCCCTACACGACGCTCTTCCGAT CT-3 ′ ) and a 3 ′ multiplexing primer (Illumina TruSeq). The DNA was purified, and qPCR was performed to accurately quantify the amount of product (Kapa Biosystems). An Illumina MiSeq sequencer was used to sequence the unique 5-nt barcodes using the 5 ′ -ILMN primer, and a 3 ′ primer was used to sequence linked 6-nt multiplex "index" sequences. The barcode and index sequences were demultiplexed to generate a table with a read count for each barcode for each animal, and these were divided by the total number of reads for each animal to generate the prevalence quotient for each plasmid. The plasmid prevalences were averaged for each time point (N = 3 for day zero, day 14, and day 42; N = 4 for day 28) (Supplemental Table S2) and then normalized to day 0 values to generate the graph in Figure  2B . Microsoft Excel was used for analysis of the data, graphing, calculation of standard deviation and standard error, and Student's t-test of biological replicates.
Mouse experiments Fah
−/− mice were provided by Markus Grompe and were maintained on 7.5 μg/mL NTBC until injection with the FAH transposon plasmids. Mice between 6 and 8 wk of age were injected with 10 µg of DNA by the hydrodynamic technique as described (Wangensteen et al. 2008) . Mouse weight and mortality were monitored until mice were euthanized at 2, 4 or 6 wk after injection. At the time of euthanasia, serum was extracted from the inferior vena cava, and separate liver lobes were harvested and either flash-frozen with dry ice or fixed with 4% paraformaldehyde. Serum biochemistries were determined by the University of Pennsylvania Mouse Phenotyping, Physiology, and Metabolism Core. Student's t-test was used to calculate statistical differences of biological replicates.
qPCR
Genomic DNA was separately extracted from whole liver lobes of three mice 1 mo after injection of an equimolar mix of FAH-GFP and FAHFoxa3 (DNeasy, Qiagen). qPCR was performed using PrimeTime primer sets (IDT DNA): a common primer set (FWD, 5 ′ -CCTACACGCGCTCTT CC-3 ′ ; REV, 5 ′ -TCAGTGGTATTTGTGAGCCA-3 ′ ; and probe, /56-FAM/ AAATTCACT/Zen/CCTCAGGTGCAGGCT/3IABkFQ/), a GFP-specific set (FWD, 5
′ -GAACCGCATCGAGCTGAA-3 ′ ; REV, 5 ′ -TGCTTGTCGG CCATGATATAG-3 ′ ; and probe, /5HEX/ATCGACTTC/ZEN/AAGGAGG ACGGCAAC/3IABkFQ/), and a Foxa3-specific set (FWD, 5
′ -CTCCTTCG TCCACACCTTATTT-3 ′ ; REV, 5 ′ -AAGGTGTCGATGTCTGTTCTG-3 ′ ; and probe, /5Cy5/AGGGTGGTTGAAGTTATAGGGCGC/3IABkFQ/). The prevalence of FAH-GFP and FAH-Foxa3 plasmids was calculated as a proportion of the total number of plasmids. Student's t-test was used to calculate the statistical differences between the biological replicates.
Histology
Fixed liver tissues were paraffinized and sectioned. IHC staining was performed using standard techniques with rabbit anti-FAH antibody (Abcam), anti-ki67, or anti-p21 followed by corresponding secondary antibodies. Immunofluorescence was performed using standard techniques with goat anti-GFP and rabbit anti-FoxA3. ImageJ was used for morphometric analysis, and Student's t-test was used to calculate statistical differences of biological replicates.
